Previous Article | Next Article ![]()
Eukaryotic Cell, September 2006, p. 1550-1559, Vol. 5, No. 9
1535-9778/06/$08.00+0 doi:10.1128/EC.00088-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, University of Minnesota, Minneapolis, Minnesota 55455
Received 27 March 2006/ Accepted 20 June 2006
|
|
|---|
|
|
|---|
The conserved Rim101/PacC pathway governs changes in gene expression through the zinc finger transcription factor Rim101/PacC, which is itself regulated by proteolytic processing. At an acidic pH, Rim101/PacC is found in either a full-length (unprocessed) form or a processed form thought to be inactive; at alkaline pH, Rim101/PacC is found in a processed form that is capable of promoting changes in gene expression (6, 19, 25, 33). Proteolytic processing is controlled by a number of upstream members of the pathway including Rim8/PalF, Rim13/PalB, Rim20/PalA, Rim21/PalH, and Snf7 (6, 8, 10, 15, 16, 19, 20, 26, 33, 34). Furthermore, many members of the ESCRT (endosomal sorting complex required for transport) machinery, which includes Snf7, are required for Rim101 processing (34). In total, these factors act to promote Rim101/PacC processing and adaptation to neutral-to-alkaline environments.
In Saccharomyces cerevisiae, Rim101 appears to act primarily as a repressor of pH-dependent gene expression. In this system, Rim101-dependent induction of targets, such as ENA1, is indirect (17, 18). Rim101 represses the expression of additional transcriptional repressors, such as Nrg1, which is a repressor of ENA1 expression. In fact, all of the Rim101 activity in S. cerevisiae can be attributed to its ability to repress transcription (17). In Aspergillus nidulans, PacC appears to directly act as both a repressor and an inducer of pH-dependent gene expression (11, 25, 29).
In Candida albicans, Rim101 acts as a repressor of genes expressed preferentially at acidic pH compared to alkaline pH and as an inducer of genes expressed preferentially at alkaline pH compared to acidic pH (4, 8, 26, 28). However, its role as an inducer is more clearly defined. For example, Rim101 is required for the induction of PHR1 at a neutral-to-alkaline pH (8, 28). Ramon and Fonzi previously demonstrated that a recombinant Rim101 DNA binding domain-glutathione S-transferase (GST) fusion binds directly to the PHR1 promoter. Furthermore, those authors showed that this binding is required for alkaline-pH-dependent induction of PHR1 (27). In A. nidulans and S. cerevisiae, PacC/Rim101 binds with high affinity to the 5'-GCCAAG sequence (17, 27, 29). However, the C. albicans PHR1 promoter does not contain a 5'-GCCAAG sequence. Interestingly, Ramon and Fonzi found that C. albicans Rim101 binds to the divergent 5'-CCAAGAA sequence. Thus, C. albicans Rim101 can act directly as an inducer of gene expression by binding to a divergent Rim101/PacC binding site.
However, C. albicans Rim101 may not be specific for the divergent 5'-CCAAGAA sequence. We identified 186 alkaline-pH-induced and Rim101-dependent genes by transcriptional profiling (4). Analysis of alkaline-pH- and Rim101-dependent promoters revealed the 5'-GCCAAGAA site as a conserved motif. This site contains both the classical 5'-GCCAAG and divergent 5'-CCAAGAA Rim101 binding sites. Thus, C. albicans Rim101 may in fact bind to a classical site motif.
While Rim101 clearly acts as an inducer in C. albicans, it is not known if it can directly act as a repressor. Rim101 binding sites can be found in the promoters of some genes repressed at alkaline pH in a Rim101-dependent manner, but analysis of the 20 most alkaline-pH-repressed Rim101-dependent promoters using the MEME algorithm did not identify a Rim101 binding site. Furthermore, in the absence of Rim101, all analyzed alkaline-pH-repressed Rim101-dependent genes became alkaline induced (4, 8). This suggests that an additional factor(s) may regulate these genes. Thus, Rim101 may indirectly govern alkaline-pH-repressed gene expression through this other factor. This situation would mirror that in S. cerevisiae, where Rim101 indirectly acts as an inducer by repression of another transcriptional repressor (17).
Here, we studied the role of C. albicans Rim101 in the repression of the PHR2 gene. PHR2 encodes a functional homolog of the Phr1 cell wall ß-glycosidase and is expressed in a pH- and Rim101-dependent manner (14, 23). However, unlike PHR1, PHR2 is expressed preferentially at acidic pH and is repressed at alkaline pH in a Rim101-dependent manner (8, 23). Sequence analysis of a 1,000-bp region of the PHR2 promoter upstream of ATG identified three potential Rim101 binding sites at positions 575, 124, and 51, suggesting that PHR2 may be directly regulated by Rim101 (Fig. 1). While all three sites are potential Rim101 binding sites, the 575 and 124 sites are in the opposite orientation. Furthermore, the 575 site specifies a classical consensus sequence, 5'-CTTGGC; the 124 site can specify both a classical and a divergent consensus sequence, 5'-TTCTTGGC; and the 51 site specifies only the divergent consensus sequence 5'-CCAAGAA. Through electrophoretic mobility shift assays (EMSAs) and LacZ reporter analyses, we found that specific Rim101 binding sites within the PHR2 promoter are important for Rim101-dependent repression at alkaline pH. Furthermore, we found that endogenous Rim101 binds to these sites in vitro and that binding does not require Rim101 processing. Thus, our studies demonstrate that Rim101 acts directly as a repressor of transcription in C. albicans. Finally, our results suggest that Rim101 binding activity is governed by an additional mechanism independent of proteolytic processing.
![]() View larger version (8K): [in a new window] |
FIG. 1. Diagram of the putative Rim101 binding sites within the PHR2 promoter. The sites at positions 575 and 124 are in the opposite orientation to the start codon. All three sequences are listed from the sense strand.
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains used in this study
|
|
View this table: [in a new window] |
TABLE 2. Primers used in this study
|
The 124 and 575 site-specific mutations were generated as follows. PPHR2-lacZ was amplified in two fragments from pDDB225 using primers Pphr2-117m1b (or Pphr2-569m1) with 3'-detect and Pphr2-117m2b (or Pphr2-569m2) with 5'SnaBICaHis1. These two fragments were introduced into NheI/ClaI-digested pDDB225 by in vivo recombination, resulting in pDDB255 for 124 site-specific mutation and pDDB256 for 575 site-specific mutation.
The double mutations at positions 51 and 124, 51 and 575, and 124 and 575 were generated by the same strategy used for the 124 and 575 site-specific mutations with the same primers using NheI/ClaI-digested pDDB254 for the double mutations at positions 51 and 124 and 51 and 575 and pDDB333 for the double mutations at positions 124 and 575 to yield pDDB334, pDDB335, and pDDB336, respectively, after in vivo recombination. The triple mutation at positions 51, 124, and 575 was generated using NheI/ClaI-digested pDDB335 to yield pDDB337.
The 124 point mutations for the classical and divergent Rim101 binding consensus sequences (GCCAAGAA) were generated by in vivo recombination between two amplified PPHR2-lacZ fragments using primers Pphr2-117 aCCAAGA 5' (or Pphr2-117 GCCAAGg-5') with 3'-detect and Pphr2-117 aCCAAGA 3' (or Pphr2-117 GCCAAGg-3') with 5'SnaBICaHis1 and NheI/ClaI-digested pDDB225 to yield pDDB338 and pDDB339, respectively.
Plasmids pDDB225, pDDB254, and pDDB332 through pDDB339 were digested with NruI and transformed into DAY1 and DAY432 to generate strains for ß-galactosidase assays. Correct integration was verified by PCR with the primers PHR2-1005 and LacZ + 354c. The PHR2 promoter region of all plasmid constructs was confirmed by sequencing.
Media and growth conditions. C. albicans was routinely grown in yeast extract-peptone-dextrose plus uridine (2% Bacto peptone, 1% yeast extract, 2% dextrose, and 80 µg of uridine per ml). Selection for the His+ transformants was done on synthetic medium (0.67% yeast nitrogen base plus ammonium sulfate and without amino acids, 2% dextrose, and 80 µg of uridine per ml supplemented with the required auxotrophic needs of the cells).
ß-Galactosidase assays. For liquid ß-galactosidase assays, cell pellets grown to mid-log phase in 35 ml of pH 4 or pH 8 M199 medium with 150 mM HEPES were resuspended in 1 ml Z buffer (1). Each cell suspension was diluted 20-fold to determine the optical density at 600 nm. One hundred fifty microliters of cell suspension was then added to a mixture of 0.1% sodium dodecyl sulfate (SDS) and chloroform for permeabilization. After a 10-min incubation at 37°C, 0.7 ml ONPG (o-nitrophenyl-ß-D-galactopyranoside) (1 mg/ml) was added for the ß-galactosidase reaction. Reactions were terminated by adding 0.5 ml 1 M Na2CO3 when the solution turned yellow, and the A420 was determined. Miller units were calculated as follows: A420/(optical density at 600 nm x volume assayed x time) (1). Data were analyzed by analysis of variance to determine statistical relationships.
Protein preparation. Cultures were grown to saturation overnight in yeast extract-peptone-dextrose plus uridine. Cells were diluted 40-fold into M199 medium buffered with 150 mM HEPES to pH 4 or pH 8 and grown for 4 h at 30°C. Cells were pelleted and stored at 80°C prior to protein extraction. Cell pellets were resuspended in ice-cold radioimmunoprecipitation assay buffer containing 1 µg/ml leupeptin, 2 µg/ml aprotinin, 1 µg/ml pepstatin, 1 mM phenylmethylsulfonyl fluoride, and 10 mM dithiothreitol and transferred into glass test tubes containing acid-washed glass beads. Cells were lysed by vortexing four times for 2 min, followed by 2 min on ice. Cell debris was removed by centrifugation, and supernatants were removed and stored at 80°C.
Western blot analyses. For Western blots, 20 µl of 2x SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer was added to 20 µl supernatant, and samples were boiled for 5 min. Samples were loaded onto an 8% SDS-PAGE gel and run overnight at 35 V. Proteins were transferred onto nitrocellulose and blocked. Anti-V5-horseradish peroxidase (HRP) antibody (Invitrogen) in 30 ml 5% nonfat milk-Tris-buffered saline-Tween solution (1:7,500 dilution) was added to the blot for 4 h at 4°C. Blots were washed in Tris-buffered saline-Tween, incubated with ECL reagent (Amersham Biosciences), and exposed to film. Blots were analyzed using ImageJ software (NIH).
EMSA.
EMSAs were performed as follows. Forty femtomoles of DNA probe was incubated with 20 µg of cell extract in 20 µl of binding buffer [10 mM Tris-HCl, pH 7.5, 4% glycerol, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM dithiothreitol, 50 mM NaCl, 2 µg of poly(dI-dC)] at room temperature for 30 min. DNA-protein complexes were resolved on 4% nondenaturing polyacrylamide gels in 0.5x Tris-borate-EDTA buffer at room temperature overnight. After electrophoresis, the gels were dried and visualized with a phosphorimager. For supershift assays, 20 µg of cell extract was incubated with 1 µg of anti-V5-HRP antibody on ice for 30 min prior to the addition of the DNA probe, and the binding reaction was allowed to proceed for an additional 30 min at room temperature. All DNA probes were end labeled by T4 polynucleotide kinase with [
-32P]dATP. EMSAs were analyzed using ImageJ software (NIH).
|
|
|---|
![]() View larger version (86K): [in a new window] |
FIG. 2. EMSA of promoter regions containing putative Rim101 binding sites. Protein extracts from wild-type (DAY286) (lanes 2, 3, 6, 7, 10, 11, 14, and 15) and rim101/ (DAY5) (lanes 4, 8, 12, and 16) strains grown at pH 8 were incubated with radiolabeled DNA probes for endogenous (+) (lanes 2 and 4) or mutated () (lane 3) PHR1 oligomers or endogenous (+) (lanes 6, 8, 10, 12, 14, and 16) or mutated () (lanes 7, 11, and 15) PHR2 (575, 124, and 51) oligomers and analyzed by EMSA. Lanes 1, 5, 9, and 13 contain free probe (fp) without protein extracts.
|
We next asked whether the gel shifts observed with the PHR2 promoter fragments were dependent on the predicted Rim101 binding sites. Oligomers in which the core sequence found in both the classical and divergent Rim101 binding sites was changed from 5'-CCAAG to 5'-CCGGC (change is underlined) were designed. Radiolabeled probes that span the 575, 124, or 51 site and that contain these mutations were generated using oligomers PHR2-569mut 5' and PHR2-569mut 3', PHR2-117mut 5' and PHR2-117mut 3', and PHR2-48mut 5' and PHR2-48mut 5', respectively. EMSA of these mutated probes incubated with protein extracts from wild-type cells revealed a dramatic decrease in the amount of probe shifted to band B but not band A, similar to results seen for the PHR1 binding site (Fig. 2, lanes 3, 7, 11, and 15). Finally, probes derived from oligomer probes PHR2-569 5' and PHR2-569 3', PHR2-117 5' and PHR2-117 3', and PHR2-48 5' and PHR2-48 5' were incubated with protein extracts from rim101/ cells and analyzed by EMSA (Fig. 2, lanes 4, 8, 12, and 16). Again, a drastic reduction in probe shifted to band B but not band A was observed, supporting the idea that these PHR2 site promoter fragments interact with Rim101 through the Rim101 binding site.
The fact that the mutated PHR1 and PHR2 DNA probes failed to interact with Rim101 strongly suggests that this interaction is specific. To further address this possibility, we conducted competition EMSAs. We first analyzed the ability of cold wild-type PHR1 or mutated PHR1 DNA fragments, generated by annealing the primer pairs described above, to compete for Rim101 binding to a radiolabeled wild-type PHR1 probe (Fig. 3). The addition of 30-fold excess cold wild-type PHR1 DNA fragment effectively abolished most of the Rim101-dependent gel shift (Fig. 3A, lane 2). However, the addition of 1,000-fold excess cold mutated PHR1 DNA fragment was required to reduce the Rim101-dependent gel shift to band B (Fig. 3A, lane 9). We noted that band A was effectively competed with either cold competitor, suggesting that this band is a nonspecific artifact. We next analyzed the ability of cold wild-type 124 and mutated 124 PHR2 DNA fragments, generated as described above, to compete for Rim101 binding to the radiolabeled wild-type 124 probe. The addition of 30-fold excess cold wild-type 124 PHR2 DNA fragment significantly reduced the Rim101-dependent gel shift (Fig. 3B, lane 2). However, the addition of 300-fold excess cold mutated 124 PHR2 DNA fragment was required to similarly reduce the Rim101-dependent gel shift (Fig. 3B, lane 8). These results support the idea that the band B gel shift is due to a specific Rim101-dependent interaction.
![]() View larger version (93K): [in a new window] |
FIG. 3. Competition assays for Rim101-dependent binding to the putative Rim101 binding sites. Protein extracts from wild-type (DAY286) cells grown at pH 8 were incubated with radiolabeled probe for PHR1 (A) or PHR2 124 (B) in the absence (lane 1) of competitor, in the presence of 30- to 1,000-fold excess wild-type (WT) (lanes 2 to 5) cold competitor, or in the presence of 30- to 1,000-fold excess mutant (mut) (lanes 6 to 9) cold competitor.
|
![]() View larger version (128K): [in a new window] |
FIG. 4. Supershift assays demonstrate that Rim101 binds to promoter regions containing the Rim101 binding site. Protein extracts from rim101/ + RIM101-V5 (DAY492) cells grown at pH 8 incubated with anti-V5-HRP antibody (V5) (lanes 3, 6, 9, and 12) or without anti-V5-HRP antibody (+) (lanes 2, 5, 8, and 11) were allowed to bind to DNA probes for wild-type PHR1 or PHR2 (575, 124, and 51) promoters. Lanes 1, 4, 7, and 10 contain free probe (fp) without protein extract.
|
30-fold when cells were grown at pH 8 compared to pH 4. In rim101/ cells, PPHR2-lacZ expression was similar to that of wild-type cells at pH 4 but was now overexpressed about two- to threefold at pH 8. These results are consistent with Northern blot data, which demonstrated that PHR2 is expressed preferentially at pH 4 compared to pH 8 in wild-type cells and was expressed about threefold more at pH 8 than at pH 4 in rim101/ cells (8). Thus, the PPHR2-lacZ construct is expressed in a pH- and Rim101-dependent manner. |
View this table: [in a new window] |
TABLE 3. PHR2 promoter LacZ fusions identify the 124 site as the critical Rim101 binding sitea
|
20-fold, which was not significantly different than that of the wild-type PPHR2-lacZ fusion (P = 0.071 and 0.48, respectively). Thus, the 51 and 575 sites do not have a dramatic effect on PHR2 pH-dependent expression.
We next mutated the 124 site from 5'-TTCTTGGC to 5'-TTgccGGC and analyzed expression. In wild-type cells at pH 4, PPHR2-124-lacZ was expressed at reduced levels compared to PPHR2-lacZ (P < 5 x 105), suggesting that bases at the 124 site may play a role in basal transcription. In wild-type cells at pH 8, PPHR2-124-lacZ showed only twofold repression, which is
15-fold less repression than that observed for PPHR2-lacZ. This suggests that the 124 site plays a dramatic role in PHR2 pH-dependent expression.
In rim101/ cells at pH 4, PPHR2-51-lacZ, PPHR2-124-lacZ, and PPHR2-575-lacZ were expressed at levels similar to those observed in wild-type cells. PPHR2-124-lacZ and PPHR2-575-lacZ were overexpressed like PPHR2-lacZ in the rim101/ background. However, at pH 8, PPHR2-51-lacZ was overexpressed significantly less than PPHR2-lacZ in the rim101/ background (P < 0.0093). These results suggest that the 51 site, but not the 124 and the 575 sites, may play a role in PHR2 Rim101-independent transcriptional regulation.
The 124 site appears to be the most important site for the pH-dependent repression of PHR2. However, alkaline-pH-dependent repression was still present in the PPHR2-124-lacZ construct. To determine if this residual repression was conferred by the 51 and/or 575 site, we constructed PPHR2-lacZ fusions that contained mutations in two or three of the putative Rim101 binding sites and analyzed expression in wild-type and rim101/ cells (Table 3).
The PPHR2-124,-575-lacZ construct had no differences in lacZ expression compared to the PPHR2-124-lacZ construct at either pH 4 or pH 8. Furthermore, in the wild-type background, the PPHR2-51,-575-lacZ double-mutant construct was not statistically different from the PPHR2-51-lacZ construct. These results support the idea that the 575 site is not critical for PHR2 pH-dependent regulation. However, the PPHR2-51,-124-lacZ construct showed a significant difference in lacZ expression compared to the PPHR2-124-lacZ construct at pH 4 (P < 0.0015), suggesting that the 51 site in conjunction with the 124 site plays a role in basal transcription. At pH 8, the PPHR2-51,-124-lacZ construct did not have any significant repression compared to pH 4 levels. This was distinct from the 124 mutation alone, which retained twofold repression. These results suggest that the 51 site contributes to the pH-dependent regulation of PHR2. Finally, we found that the PPHR2-51,-124,-575-lacZ construct showed no significant differences compared to the PPHR2-51,-124-lacZ construct in either the wild-type or rim101/ background regardless of pH. These results demonstrate that Rim101-dependent repression is conferred by the 51 and 124 sites alone and that the 575 site does not play a role in the Rim101- or pH-dependent regulation of PHR2.
The 124 site acts as a classical Rim101 binding site.
Based on the LacZ assays, the 124 Rim101 binding site is the primary site for pH- and Rim101-dependent expression. Interestingly, this site is both a classical and a divergent site (5'-TTCTTGGC). To determine if this site is acting as either a classical or a divergent site, we conducted EMSAs using mutations in nucleotides specific for either the classical (the C in position 8) or the divergent (the T in position 2) sites. Protein extracts from wild-type cells shifted the radiolabeled DNA fragment spanning the wild-type 124 site but not a mutated 124 site (Fig. 2 and 5, lanes 1 and 2). Importantly, protein extracts from wild-type cells were also unable to shift the DNA fragments containing a mutation in either the classical site (
C) or the divergent site (
D) (Fig. 5, lanes 3 and 4). Based on these results, nucleotides specific to both the classical and divergent sites of the 124 site are critical for Rim101 binding in vitro.
![]() View larger version (58K): [in a new window] |
FIG. 5. The 124 site acts as a classical and divergent Rim101 binding site by EMSA. Protein extracts from wild-type (DAY286) cells grown at pH 8 were incubated with DNA probes for the endogenous (+), the mutated (), the classical-site mutated ( C), and the divergent-site mutated ( D) sequences of the 124 PHR2 site.
|
C-lacZ and PPHR2-124
D-lacZ, respectively. These constructs were introduced into the wild-type and rim101/ backgrounds, and ß-galactosidase activity was determined (Table 3). In wild-type cells at pH 4, mutation of either the classical or the divergent site reduced expression compared to the PPHR2-lacZ construct (P < 0.004 and P < 3 x 105, respectively), although the divergent site mutation had a greater reduction in expression, similar to that observed for the PPHR2-124-lacZ construct at pH 4. At pH 8, the classical-site mutation resulted in about fourfold repression compared to that at pH 4; the divergent-site mutation resulted in about eightfold repression. While mutation of the classical and divergent sites reduced pH-dependent repression compared to the PPHR2-lacZ construct, the classical site mutation had the greatest effect on pH-dependent repression. These results demonstrate that the C in position 8 of the 124 site, which specifies a classical Rim101 binding site, is important for pH-dependent expression. Rim101 processing is not required for DNA binding. Previous studies, as well as those described above, demonstrated that Rim101 can bind to Rim101-dependent promoters (27). However, these analyses did not address whether Rim101 processing affects DNA binding. To address this question, EMSAs were conducted using protein extracts from a rim13/ strain, which does not process Rim101 (19). Using whole-cell extracts from rim13/ cells grown at pH 8, in the presence of the PHR1, PHR2 575, PHR2 124, or PHR2 51 radiolabeled probes, a gel shift was observed (Fig. 6, lanes 1, 3, 5, and 7). However, in the presence of the PHR1, PHR2 575, PHR2 124, or PHR2 51 radiolabeled probes containing a mutated Rim101 binding site, a dramatic reduction in gel shift was observed (Fig. 6, lanes 2, 4, 6, and 8). These results are similar to those observed for protein extracts from wild-type cells and demonstrate that full-length Rim101 can bind to the Rim101 binding site.
![]() View larger version (81K): [in a new window] |
FIG. 6. Rim101 processing is not required for DNA binding by EMSA. Protein extracts from rim13/ + RIM101-V5 (DAY643) cells grown at pH 8 were incubated with radiolabeled DNA probes for the endogenous (+) (lanes 1, 3, 5, and 7) or mutated () (lanes 2, 4, 6, and 8) PHR1 promoter or PHR2 (575, 124, and 51) promoters.
|
![]() View larger version (88K): [in a new window] |
FIG. 7. EMSAs show that Rim101 DNA binding ability is affected by environmental pH. Protein extracts from rim101/ + RIM101-V5 (DAY492) (A) and rim13/ + RIM101-V5 (DAY643) (B) cells grown at pH 4 (lanes 1 to 8) and pH 8 (lanes 9 to 16) were incubated with radiolabeled DNA probes for endogenous (+) PHR1 (lanes 1 and 9); mutated () PHR1 (lanes 2 and 10); endogenous (+) PHR2 at the 575 (lanes 3 and 11), 124 (lanes 5 and 13), and 51 (lanes 7 and 15) sites; or mutated () PHR2 at the 575 (lanes 4 and 12), 124 (lanes 6 and 14), and 51 (lanes 8 and 16) sites and analyzed by EMSA. Protein samples (250 µg) from rim101/ + RIM101-V5 (A, lanes 17 and 18) and rim13/ + RIM101-V5 (B, lanes 17 and 18) grown at pH 4 (lane 17) or pH 8 (lane 18) were analyzed by Western blotting. The 75-kDa molecular mass marker, full-length (FL) Rim101-V5, and processed (P1 and P2) Rim101-V5 are noted.
|
|
|
|---|
The PHR2 promoter contains three sequences that are predicted classical or divergent Rim101 binding sites (13, 27). The most distal site, at position 575, is strictly a classical Rim101 binding site (5'-CTTGGC). We found that Rim101 could bind to this site in vitro; however, the 575 site is not required for pH-dependent regulation in vivo. Thus, Rim101 binding to the 575 site in vivo is neither necessary nor sufficient to repress PHR2 expression. The most proximal site, at position 51, is strictly a divergent Rim101 binding site (5'-CCAAGAA). We found that Rim101 could also bind to this site in vitro. However, in vivo studies demonstrated that while the 51 site is not required for pH-dependent regulation, it can play a role when the 124 site is mutated (see below).
The 124 site can specify both a classical and a divergent site (5'-TTCTTGGC), and this site binds Rim101 in vitro. However, unlike the 51 and 575 sites, the 124 site confers most of the pH-dependent regulation observed for PHR2. While the 124 site is required for PHR2 repression, there is still residual repression when the 124 site is mutated. This residual repression is now dependent on the 51 site, suggesting that this site may indeed be involved in PHR2 regulation in vivo.
In the absence of Rim101, the normally alkaline-pH-repressed PHR2 becomes an alkaline-pH-induced gene. Interestingly, we found that mutation of the 51 site, but not the 124 or the 575 site, impaired alkaline induction in the rim101/ background. In all cases where the 51 site is intact, lacZ is induced more than twofold at alkaline pH in the rim101/ background. However, in all cases where the 51 site is mutated, lacZ is induced less than twofold at alkaline pH in the rim101/ background. One possibility is that this region of the PHR2 promoter is important for RNA polymerase binding or stability. However, lacZ expression at acidic pH is similar when driven from the PHR2 promoter containing an intact 51 site, a mutated 51 site, and the mutated 51 and 575 sites, suggesting that the 51 site is not required for general transcription. Thus, the 51 site may recruit a factor that promotes gene expression at alkaline pH in the absence of Rim101.
What is the Rim101 binding site? Previous work of Ramon and Fonzi, and work also described here, clearly demonstrates that C. albicans Rim101 does not require the first G of the classical site for binding (see Fig. 2, specifically, the PHR1 and the PHR2 51 lanes). This is contrary to findings for A. nidulans, which demonstrated that any other nucleotide in the first position besides G resulted in markedly reduced GST-PacC binding (13). However, in C. albicans, the requirement for a G in this position is binding site dependent. For the PHR1 Rim101 binding site and the PHR2 51 site, there is no G in the first position, yet Rim101 binds to these sites in vitro, and these sites are relevant in vivo. However, for the PHR2 124 site, there is a G in the first position that is essential for Rim101 binding in vitro and important for repression in vivo. Computer analysis of promoters from Rim101-dependent alkaline-pH-induced genes identified the consensus sequence GCCAAGAA, supporting the idea that the first G is often important for Rim101-dependent regulation (4). Thus, we propose that, in general, the Rim101 binding site can be considered GCCAAGAA, although divergence from this site can be tolerated. Support for this idea comes from A. nidulans. For example, the A in position 5 of the PacC site is frequently a G (5'-GCCAGG), although this results in lower-affinity binding (12). Furthermore, in the gabA promoter, the A in position 4 can be changed with no apparent effect on PacC binding (11); however, in the ipnA promoter, the A in position 4 is essential for PacC binding (29). Finally, our EMSAs revealed that Rim101 binds more efficiently to the Rim101 binding site of the PHR1 promoter than to any of the PHR2 binding sites, including the 51 and 124 sites, which share the CCAAGAA sequence. This result is supported by competition studies (unpublished data). Thus, we suggest that the ability of Rim101 to bind to the consensus sequence GCCAAGAA is context dependent.
Why is the 575 site dispensable for Rim101-mediated PHR2 regulation? One possibility is that the orientation of the binding site is important for Rim101-dependent regulation. This does not seem likely, since the 124 site, which plays the major role in PHR2 repression, is in the same orientation as the 575 site. Another possibility is that this site is too far away from the transcriptional start site. In the case of the PHR1 promoter, the Rim101 binding sites are located at positions 516 and 825. Thus, the distance from the transcriptional start site does not appear to be a sufficient explanation. However, if Rim101 repression is mediated by inhibiting the binding of an activator, then binding site location is critical. In A. nidulans, expression of gabA is governed by the transcriptional activator IntA (3). However, gabA is repressed at alkaline pH in a PacC-dependent manner. Repression occurs because the PacC binding sites overlap with the IntA binding site (11). At alkaline pH, PacC is active and binds to the gabA promoter, which excludes IntA from binding to its site. Thus, we propose that a similar mechanism may occur in C. albicans PHR2 Rim101-dependent repression. Support for this model comes from the fact that in the absence of Rim101, PHR2 becomes an alkaline-pH-induced gene, suggesting that additional factors are at play.
Our results strongly suggest the existence of additional regulatory factors that govern PHR2 expression. First, as stated above, PHR2 becomes an alkaline-pH-induced gene in the absence of Rim101. If Rim101 were the only factor involved in expression, then PHR2 should be expressed similarly at acidic and alkaline pHs. This additional regulatory control does not appear to be PHR2 specific, as several genes repressed at alkaline pH in a Rim101-dependent manner become alkaline induced in the absence of Rim101 (4). Second, from our EMSAs, we have found at least one additional DNA-protein complex that results in a band that we refer to as band A (see Fig. 2, for example). While this band may be a nonspecific artifact, it appears that the 51 site was not as efficiently shifted to band A compared to the PHR1 binding site or the PHR2 124 and 575 sites, suggesting some specificity in binding (Fig. 4). For example, all of the sequences that are shifted to band A also contain an uninterrupted stretch of eight to nine A residues, whereas the longest run of As in the 51 site is three residues.
Finally, we found that Rim101 binding to DNA is dependent on the pH in which the cells were grown. This pH-dependent binding was not an attribute of processing, as Rim101 isolated from rim13/ cells was able to efficiently bind to the Rim101 binding site when isolated from cells grown at alkaline pH but not when isolated from cells grown at acidic pH. Thus, we propose that at acidic pH, Rim101 binding activity is inhibited by an as-yet-unidentified factor or that at alkaline pH, Rim101 binding activity is promoted by an unidentified factor. Regardless, we are unaware of any previous descriptions of Rim101 regulation except for the well-described proteolytic processing. Thus, in addition to proteolytic activation, C. albicans appears to have at least one additional mechanism to regulate Rim101 activity.
This work of Dana A. Davis is supported by NIH National Institute of Allergy and Infectious Disease award 1R01-AI064054 [GenBank] -01 and by the Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»